Cytokine networks—towards new therapies for rheumatoid arthritis (original) (raw)
Feldmann M and Maini RN (2001) Anti-TNF alpha therapy of rheumatoid arthritis: what have we learned? Annu Rev Immunol19: 163–196 ArticleCASPubMed Google Scholar
van Jaarsveld CH et al. (1999) The prognostic value of the antiperinuclear factor, anti-citrullinated peptide antibodies and rheumatoid factor in early rheumatoid arthritis. Clin Exp Rheumatol17: 689–697 CASPubMed Google Scholar
Brennan FM et al. (1989) Inhibitory effect of TNF alpha antibodies on synovial cell interleukin-1 production in rheumatoid arthritis. Lancet2: 244–247 ArticleCASPubMed Google Scholar
Klareskog L et al. (2004) Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomized controlled trial. Lancet363: 675–681 ArticleCASPubMed Google Scholar
Takagi N et al. (1998) Blockage of interleukin-6 receptor ameliorates joint disease in murine collagen-induced arthritis. Arthritis Rheum41: 2117–2121 ArticleCASPubMed Google Scholar
Choy EH et al. (2002) Therapeutic benefit of blocking interleukin-6 activity with an anti-interleukin-6 receptor monoclonal antibody in rheumatoid arthritis: a randomized, double-blind, placebo-controlled, dose-escalation trial. Arthritis Rheum46: 3143–3150 ArticleCASPubMed Google Scholar
Nakahara H et al. (2003) Anti-interleukin-6 receptor antibody therapy reduces vascular endothelial growth factor production in rheumatoid arthritis. Arthritis Rheum48: 1521–1529 ArticleCASPubMed Google Scholar
Nishimoto N et al. (2004) Treatment of rheumatoid arthritis with humanized anti-interleukin-6 receptor antibody: a multicenter, double-blind, placebo-controlled trial. Arthritis Rheum50: 1761–1769 ArticleCASPubMed Google Scholar
Yokota S et al. (2005) Therapeutic efficacy of humanized recombinant anti-interleukin-6 receptor antibody in children with systemic-onset juvenile idiopathic arthritis. Arthritis Rheum52: 818–825 ArticleCASPubMed Google Scholar
Pelletier JP and Martel-Pelletier J (2003) Oncostatin M: foe or friend? Arthritis Rheum48: 3301–3303 ArticlePubMed Google Scholar
Hui W et al. (2003) Oncostatin M in combination with tumor necrosis factor alpha induces cartilage damage and matrix metalloproteinase expression in vitro and in vivo. Arthritis Rheum48: 3404–3418 ArticleCASPubMed Google Scholar
Hui W et al. (2005) A model of inflammatory arthritis highlights a role for oncostatin M in pro-inflammatory cytokine-induced bone destruction via RANK/RANKL. Arthritis Res Ther7: R57–R64 ArticlePubMedCAS Google Scholar
Waldmann TA and Tagaya Y (1999) The multifaceted regulation of interleukin-15 expression and the role of this cytokine in NK cell differentiation and host response to intracellular pathogens. Annu Rev Immunol17: 19–49 ArticleCASPubMed Google Scholar
Budagian V et al. (2004) Reverse signaling through membrane-bound interleukin-15. J Biol Chem279: 42192–42201 ArticleCASPubMed Google Scholar
Dubois S et al. (2002) IL-15Rα recycles and presents IL-15 in trans to neighboring cells. Immunity17: 537–547 ArticleCASPubMed Google Scholar
McInnes IB et al. (2003) New strategies to control inflammatory synovitis: interleukin 15 and beyond. Ann Rheum Dis62: 51–54 Article Google Scholar
McInnes IB et al. (1997) Interleukin-15 mediates T cell-dependent regulation of tumor necrosis factor-α production in rheumatoid arthritis. Nat Med3: 189–195 ArticleCASPubMed Google Scholar
Ruchatz H et al. (1998) Soluble IL-15 receptor alpha-chain administration prevents murine collagen-induced arthritis: a role for IL-15 in development of antigen-induced immunopathology. J Immunol160: 5654–5660 CASPubMed Google Scholar
Ferrari-Lacraz S et al. (2004) Targeting IL-15 receptor-bearing cells with an antagonist mutant IL-15/Fc protein prevents disease development and progression in murine collagen-induced arthritis. J Immunol173: 5818–5826 ArticleCASPubMed Google Scholar
Baslund B et al. (2005) Targeting interleukin-15 in patients with rheumatoid arthritis: a proof-of-concept study. Arthritis Rheum52: 2686–2692 ArticleCASPubMed Google Scholar
McInnes IB et al. (2004) Safety and efficacy of a human monoclonal antibody to IL-15 (AMG 714) in patients with rheumatoid arthritis (RA): results from a multicenter, randomized, double-blind, placebo-controlled trial [abstract]. Arthritis Rheum50 (Suppl): a241 Google Scholar
Zheng XX et al. (2003) Favorably tipping the balance between cytopathic and regulatory T cells to create transplantation tolerance. Immunity19: 503–514 ArticleCASPubMed Google Scholar
Schulze-Koops H and Kalden JR (2001) The balance of Th1/Th2 cytokines in rheumatoid arthritis. Best Pract Res Clin Rheumatol15: 677–691 ArticleCASPubMed Google Scholar
Veys EM et al. (1997) A randomized, double-blind study comparing twenty-four-week treatment with recombinant interferon-gamma versus placebo in the treatment of rheumatoid arthritis. Arthritis Rheum40: 62–68 ArticleCASPubMed Google Scholar
Sigidin YA et al. (2001) Randomized, double-blind trial of anti-interferon-gamma antibodies in rheumatoid arthritis. Scand J Rheumatol30: 203–207 ArticleCASPubMed Google Scholar
Kolls JK and Linden A (2004) Interleukin-17 family members and inflammation. Immunity21: 467–476 ArticleCASPubMed Google Scholar
Chabaud M et al. (1999) Human interleukin-17: a T cell-derived proinflammatory cytokine produced by the rheumatoid synovium. Arthritis Rheum42: 963–970 ArticleCASPubMed Google Scholar
Lubberts E et al. (2005) The role of T cell interleukin-17 in conducting destructive arthritis: lessons from animal models. Arthritis Res Ther7: 29–37 ArticleCASPubMed Google Scholar
Rooney T et al. (2004) Synovial tissue interleukin-18 expression and the response to treatment in patients with inflammatory arthritis. Ann Rheum Dis63: 1393–1398 ArticleCASPubMedPubMed Central Google Scholar
Joosten LA et al. (2004) Interleukin-18 promotes joint inflammation and induces interleukin-1-driven cartilage destruction. Am J Pathol165: 959–967 ArticleCASPubMedPubMed Central Google Scholar
Wei XQ et al. (2001) Reduced incidence and severity of collagen-induced arthritis in mice lacking IL-18. J Immunol166: 517–521 ArticleCASPubMed Google Scholar
Plater-Zyberk C et al. (2001) Therapeutic effect of neutralizing endogenous IL-18 activity in the collagen-induced model of arthritis. J Clin Invest108: 1825–1832 ArticleCASPubMedPubMed Central Google Scholar
Smeets RL et al. (2003) Adenoviral delivery of IL-18 binding protein C ameliorates collagen-induced arthritis in mice. Gene Ther10: 1004–1011 ArticleCASPubMed Google Scholar
Morita Y et al. (1998) Expression of interleukin-12 in synovial tissue from patients with rheumatoid arthritis. Arthritis Rheum41: 306–314 ArticleCASPubMed Google Scholar
Hess H et al. High doses of interleukin-12 inhibit the development of joint disease in DBA/1 mice immunized with type II collagen in complete Freund's adjuvant. Eur J Immunol26: 187–191
Leung BP et al. (2000) Combined effects of IL-12 and IL-18 on the induction of collagen-induced arthritis. J Immunol164: 6495–6502 ArticleCASPubMed Google Scholar
Malfait AM et al. (1998) Blockade of IL-12 during the induction of collagen-induced arthritis (CIA) markedly attenuates the severity of the arthritis. Clin Exp Immunol111: 377–383 ArticleCASPubMedPubMed Central Google Scholar
Joosten LA et al. (1997) Dual role of IL-12 in early and late stages of murine collagen type II arthritis. J Immunol159: 4094–4102 CASPubMed Google Scholar
Butler DM et al. (1999) Anti-IL-12 and anti-TNF antibodies synergistically suppress the progression of murine collagen-induced arthritis. Eur J Immunol29: 2205–2212 ArticleCASPubMed Google Scholar
Joosten LA et al. (2002) Local interleukin-12 gene transfer promotes conversion of an acute arthritis to a chronic destructive arthritis. Arthritis Rheum46: 1379–1389 ArticleCASPubMed Google Scholar
Trinchieri G et al. (2003) The IL-12 family of heterodimeric cytokines: new players in the regulation of T cell responses. Immunity19: 641–644 ArticleCASPubMed Google Scholar
Murphy CA et al. (2003) Divergent pro- and anti-inflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation. J Exp Med198: 1951–1957 ArticleCASPubMedPubMed Central Google Scholar
Goldberg R et al. (2004) Suppression of ongoing adjuvant-induced arthritis by neutralizing the function of the p28 subunit of IL-27. J Immunol173: 1171–1178 ArticleCASPubMed Google Scholar
Kauffman CL et al. (2004) A phase I study evaluating the safety, pharmacokinetics, and clinical response of a human IL-12 p40 antibody in subjects with plaque psoriasis. J Invest Dermatol123: 1037–1044 ArticleCASPubMed Google Scholar
Sattar N et al. (2003) Explaining how “high-grade” systemic inflammation accelerates vascular risk in rheumatoid arthritis. Circulation108: 2957–2963 ArticlePubMed Google Scholar
Bokarewa M et al. (2005) Resistin, an adipokine with potent proinflammatory properties. J Immunol174: 5789–5795 ArticleCASPubMed Google Scholar
Kokkola R et al. (2002) High mobility group box chromosomal protein 1: a novel proinflammatory mediator in synovitis. Arthritis Rheum46: 2598–2603 ArticleCASPubMed Google Scholar
Kokkola R et al. (2003) Successful treatment of collagen-induced arthritis in mice and rats by targeting extracellular high mobility group box chromosomal protein 1 activity. Arthritis Rheum48: 2052–2058 ArticleCASPubMed Google Scholar
Bekker PJ et al. (2004) A single-dose placebo-controlled study of AMG 162, a fully human monoclonal antibody to RANKL, in postmenopausal women. J Bone Miner Res19: 1059–1066 ArticleCASPubMed Google Scholar
Tan SM et al. (2003) Local production of B lymphocyte stimulator protein and APRIL in arthritic joints of patients with inflammatory arthritis. Arthritis Rheum48: 982–992 ArticleCASPubMed Google Scholar
Cohen SB (2004) The use of anakinra, an interleukin-1 receptor antagonist, in the treatment of rheumatoid arthritis. Rheum Dis Clin North Am30: 365–380 ArticlePubMed Google Scholar
Choe JY et al. (2003) Interleukin 1 receptor dependence of serum transferred arthritis can be circumvented by toll-like receptor 4 signaling. J Exp Med197: 537–542 ArticleCASPubMedPubMed Central Google Scholar